Health Care Equipment

In recent years, traders and investors have increasingly turned to social media to discuss their investments. Now, interested parties can get a scientific look at what is being discussed on a weekly, monthly, and even hourly basis. Provided by Social Market Analytics, here is the social media...

According to a research report published this morning, Goldman Sachs has lowered MAKO Surgical's (NASDAQ: MAKO) PT from $49 to $42. Goldman Sachs said in the report, "MAKO Surgical reported 1Q2012 revenue of $19.6 mn, 19% below our estimate and 17.6% below the Street, and a loss per share of $0.28...

According to a research report published this morning, Piper Jaffray has lowered MAKO Surgical's (NASDAQ: MAKO) PT from $50 to $49. In the report, Piper Jaffray commented, "MAKO's shortfall on robots and implants was disappointing, only partially offset by upside to hips. While the 2-3 deals that...

Atlantic Equities downgraded El Paso Corp (NYSE: EP) from “neutral” to “underweight.” EP's shares closed at $29.80 yesterday. El Paso's trailing-twelve-month profit margin is 3.22%. Analysts at RW Baird downgraded Thomas & Betts Corp (NYSE: TNB) from “outperform” to “neutral.” TNB's shares...

Masimo (NASDAQ: MASI) today announced it has signed a three-year, dual-source agreement with Novation, the healthcare contracting services company of VHA Inc. and the University Health System Consortium (UHC). The agreement, effective May 1, 2012, covers Masimo SET® pulse oximetry and Masimo...

According to a research report published this morning, Canaccord Genuity has decreased LeMaitre Vascular's (NASDAQ: LMAT) PT from $7.50 to $7.00. In the report, Canaccord Genuity said, "Q1 results were mixed. Revenue beat expectations, while operating income was lower than expected owing to weak...

Masimo (NASDAQ: MASI) today announced the full market release of low-profile sensors to monitor oxygen saturation in newborns. The newly enhanced low-profile LNCS®, M-LNCS Neo®, NeoPt®, and Inf Sensors® are smaller and thinner, making them significantly more comfortable for patients and easier to...

Stifel Nicolaus initiates its coverage on M/A-COM Technology Solutions (NASDAQ: MTSI) with a Buy rating and a price target of $26, reflecting shirt from captive to merchant in specialized Radio Frequency, which should expand share growth. Stifel Nicolaus comments, "We believe M/A-COM's diverse...

According to a research report this morning, J.P. Morgan initiates the leading provider of high-performance RF, microwave, and millimeter-wave semiconductor components and solutions, M/A-COM (NASDAQ: MTSI), with an Overweight rating and a PT of $25. J.P. Morgan explained, “We believe market share...

Masimo (NASDAQ: MASI) today announced that Essential Medical Devices, Inc. dismissed all outstanding claims against Masimo in the patent case it had filed against Masimo and Cercacor. Masimo did not incur any liability to Essential Medical, and the dismissal included a covenant not to sue on the...

In a report released earlier today, Oppenheimer Holdings announced it is initiating coverage of MAKO Surgical Corp. (NASDAQ: MAKO) with a Perform rating, but did not set a price target. Oppenheimer went on to say in the report “With its robotically-assisted system, MAKO is leading the joint-...

Masimo (NASDAQ: MASI) announced the China State Food and Drug Administration and South Korea Food and Drug Administration regulatory clearances of Masimo Pronto-7™ – enabling clinicians throughout both countries to conveniently and noninvasively measure total hemoglobin (SpHb®), SpO2, pulse rate,...

Author: John Gerard Lewis, Gerard Wealth Covestor model: Stable High Yield Are you a “Home Gamer”? Jim Cramer says you are. That's how the ubiquitous CNBC Pied Piper refers to his viewers. And it's not an altogether faulty label – Cramer is indeed urging them to play a game. Many of the Home...

Shares of MAKO Surgical (NASDAQ: MAKO) are continuing their recent run during Wednesday's trading session. The stock has jumped another 3.46% to $43.44 and is closing in on a new 52-week high above $43.84. Over the last 5 trading sessions, MAKO is up 13.57% and during the last 3 months the stock...

Shares of MAKO Surgical (NASDAQ: MAKO) are surging on Monday and heavy volume has come into the stock over the last few minutes. At last check, MAKO shares had added 8.39% to $41.71 and were sitting at session highs. The 52-week high in the name at $43.00 could be challenged later in the trading...